Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2017
18th World Conference on Lung Cancer
Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan
Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Download PDF of the Conference Program: Click Here.
Presentations will be available 24 hours after their live presentation time
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
-
+
P1.13 - Radiology/Staging/Screening
- Type: Poster Session with Presenters Present
- Track: Radiology/Staging/Screening
- Presentations: 15
- Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P1.13-001 - T1 Tumor(≪3cm) with Visceral Pleural Invasion Should Be Classified as T2a in the 8th TNM Classification for Lung Cancer
09:30 - 09:30 | Presenter: Jia-Tao Zhang
- Abstract
Loading... -
+
P1.13-002 - New Clinical T Classification Is Associated with Pathological Stage I Invasive Adenocarcinoma with Solid Histologic Subtype
09:30 - 09:30 | Presenter: Yutaka Sawai
- Abstract
Loading... -
+
P1.13-003 - Recurrence Dynamics in Resected Pathological Stage I Lung Adenocarcinoma Depend on the IASLC/ATS/ERS Histological Subtype
09:30 - 09:30 | Presenter: Yusuke Takahashi
- Abstract
Loading... -
+
P1.13-004 - The Role of Lymph Node Staging by EBUS-TBNA in Stereotactic Body Radiation Therapy for patients with Non-Small Cell Lung Cancer.
09:30 - 09:30 | Presenter: Kohei Hashimoto
- Abstract
Loading... -
+
P1.13-005 - Is Tumor Size for the T4 Descriptor in Lung Cancer Staging Appropriate?
09:30 - 09:30 | Presenter: Junji Ichinose
- Abstract
Loading... -
+
P1.13-006 - The Value of F-18 FDG PET/CT-guided EBUS-TBNA in Nodal Staging of NSCLC.
09:30 - 09:30 | Presenter: Sung Yong Lee
- Abstract
Loading... -
+
P1.13-007 - Is Central Lung Tumor Location Really Predictive for Occult Mediastinal Nodal Disease in (Suspected) NSCLC Staged cN0 on PET-CT?
09:30 - 09:30 | Presenter: Herbert Decaluwe
- Abstract
Loading... -
+
P1.13-008 - Evaluation of Clinical Associated Factors for Lung Adenocarcinoma by TNM 8th Edition with Unexpected N2 disease
09:30 - 09:30 | Presenter: Yoshiteru Kidokoro
- Abstract
Loading... -
+
P1.13-009 - Macroscopic and Microscopic Lymphatic Remodeling Caused by VEGF-C Play a Key Role in Lymphatic Metastasis of Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Hiromitsu Takizawa
- Abstract
Loading... -
+
P1.13-010 - Is MRI Brain Mandatory in All Patients with Early Stage NSCLC?
09:30 - 09:30 | Presenter: George Karimundackal
- Abstract
Loading... -
+
P1.13-011 - Prospective Cohort Study of Patterns of Staging and Treatment Selection with or Without Multidisciplinary (MD) Care
09:30 - 09:30 | Author(s): F.E. Rugless
- Abstract
Loading... -
+
P1.13-011a - Stratification Based on PET/CT Findings for Malignant Grade of Radiologically Pure Solid Small-Sized (≪ 2cm) Lung Cancer
09:30 - 09:30 | Presenter: Norifumi Tsubokawa
- Abstract
Loading... -
+
P1.13-011b - Nodal Status Based on the Anatomical Location or the Number of Lymph Nodes Metastasis
09:30 - 09:30 | Presenter: K. Masai
- Abstract
Loading... -
+
P1.13-011c - A Study on the Prognosis of Hilar and Interpulmonary Lymph Nodes Patients with Pathologic T1N1M0 and T2N1M0 Disease in NSCLC
09:30 - 09:30 | Presenter: Jun Suzuki
- Abstract
Loading... -
+
P1.13-011d - Risk of Pleural Recurrence After Percutaneous Transthoracic Needle Biopsy in Stage I Non-Small Cell Lung Cancer: A Large Center Experience
09:30 - 09:30 | Presenter: Su Yeon Ahn
- Abstract
Loading...
-
+
P1.14 - Radiotherapy
- Type: Poster Session with Presenters Present
- Track: Radiotherapy
- Presentations: 19
- Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P1.14-001 - The Feasibility of Predicting Radiation Pneumonitis Using Lung Equivalent Uniform Dose (LEUD) in Volumetric-Modulated Arc
09:30 - 09:30 | Presenter: Xiadong Li
- Abstract
Loading... -
+
P1.14-002 - Comparison Between Stereotactic and Conventional Radiotherapy for Solitary Lung Tumors After Resection of Lung Cancer
09:30 - 09:30 | Presenter: Shigeo Takahashi
- Abstract
Loading... -
+
P1.14-003 - Anesthesia Allows Safe Administration of SBRT for Early Stage Lung Cancer Patients with Advanced Cognitive Impairments
09:30 - 09:30 | Presenter: Gregory M.M. Videtic
- Abstract
Loading... -
+
P1.14-004 - Outcomes of Stereotactic Body Radiotherapy and Surgery in Treating Early Stage Non-Small Cell Lung Cancer: A Meta-Analysis
09:30 - 09:30 | Presenter: Liang Wang
- Abstract
Loading... -
+
P1.14-005 - Development of a Novel Spacer to Reduce Mediastinal Organ Toxicity from Stereotactic Body Radiotherapy
09:30 - 09:30 | Presenter: Yusuke Muranishi
- Abstract
Loading... -
+
P1.14-006 - Carbon-Ion Radiotherapy for Isolated Lymph Node Metastasis from Lung Cancer Using a Regimen of 12 Fractions during 3 Weeks
09:30 - 09:30 | Presenter: Katsuyuki Shirai
- Abstract
Loading... -
+
P1.14-007 - Mesenchymal Stem Cells Labeled with Fluorescent Magnetic Nanoparticles for Targeted Imaging and Hyperthermia Therapy of Lung Cancer
09:30 - 09:30 | Presenter: Runlei Hu
- Abstract
Loading... -
+
P1.14-008 - Elevated Platelet Levels Affect Prognosis in Patients with NSCLC Treated with Curatively Intended Chemoradiotherapy
09:30 - 09:30 | Presenter: Georg Holgersson
- Abstract
Loading... -
+
P1.14-009 - Comparison of Dosimetric Parameters and Outcome in Non-Small Cell Lung Cancer Patients Having 3D Conformal or VMAT Plans
09:30 - 09:30 | Presenter: Nur Abdul Satar
- Abstract
Loading... -
+
P1.14-010 - SGA Could Be a Predictive Factor for Radiation Pneumonitis in Lung Cancer Patients Treated by Concurrent Chemoradiotherapy
09:30 - 09:30 | Author(s): L. Ma
- Abstract
Loading... -
+
P1.14-011 - An Esophagus-Sparing Technique to Limit Radiation Esophagitis in Locally Advanced NSCLC Treated by SIB-IMRT and Concurrent Chemotherapy
09:30 - 09:30 | Presenter: Hui Liu
- Abstract
Loading... -
+
P1.14-012 - Hypofractionated Simultaneous Integrated Boost IMRT Concurrent with Chemotherapy Improved Loco-Regional Control in Locally Advanced NSCLC
09:30 - 09:30 | Author(s): Bo Qiu
- Abstract
Loading... -
+
P1.14-013 - High Dose Radiotherapy (74Gy) Improved Local Progression Free Survival in Patients with Inoperable Stage III NSCLC
09:30 - 09:30 | Presenter: Young Il Kim
- Abstract
Loading... -
+
P1.14-014 - Comparative Evaluation of VMAT & 3D-CRT in Locally Advanced NSCLC: Is There Any Radiobiological Advantage?
09:30 - 09:30 | Author(s): S. Roy
- Abstract
Loading... -
+
P1.14-015 - Local Recurrence Rate and Timing after Stereotactic Body Radiotherapy for Lung Cancer: Need for Long-term Follow-up
09:30 - 09:30 | Presenter: Takashi Shintani
- Abstract
Loading... -
+
P1.14-016 - Assessing the Feasibility of FLT-PET for Evaluation of Non-Small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiotherapy (SBRT)
09:30 - 09:30 | Author(s): H. Raziee
- Abstract
Loading... -
+
P1.14-017 - Impact of Systematic EBUS-TBNA Mediastinal Staging on Radical Radiotherapy Planning in NSCLC
09:30 - 09:30 | Presenter: Nicholas Hardcastle
- Abstract
Loading... -
+
P1.14-018 - Construction and Evaluation of RapidPlanTM Models for Radical Lung Planning
09:30 - 09:30 | Author(s): Y. Flanagan
- Abstract
Loading... -
+
P1.14-018a - Stereotactic Ablative Radiotherapy for Ultra-Central Lung Tumors: Optimize Tumor Control or Minimize Toxicity?
09:30 - 09:30 | Author(s): Joanna M Laba
- Abstract
Loading...
-
+
P1.15 - SCLC/Neuroendocrine Tumors
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors
- Presentations: 17
- Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P1.15-001 - Ipilimumab Increases Th1/Th2 and Inflammatory Cytokines Counteracting Chemotherapy Effects in Small Cell Lung Cancer
09:30 - 09:30 | Author(s): M. Hardy-Werbin
- Abstract
Loading... -
+
P1.15-002 - A Retrospective Study of Amrubicin Monotherapy for the Treatment of Relapsed Small Cell Lung Cancer in Elderly Patients
09:30 - 09:30 | Presenter: Hiroyuki Minemura
- Abstract
Loading... -
+
P1.15-003 - Survival by Response to First-line Platinum-Based Therapy Among Patients With Extensive Disease Small Cell Lung Cancer
09:30 - 09:30 | Author(s): M.D. Danese
- Abstract
Loading... -
+
P1.15-004 - An Open-Label, Multitumor Phase II Basket Study of Olaparib and Durvalumab (MEDIOLA): Results in Patients with Relapsed SCLC
09:30 - 09:30 | Presenter: Matthew G Krebs
- Abstract
Loading... -
+
P1.15-005 - Relationship Between MYC Family Status and Sensitivity to Aurora Kinase Inhibitors in Neuroendocrine and Other Lung Cancer Cell Lines
09:30 - 09:30 | Presenter: Tomohiro Haruki
- Abstract
Loading... -
+
P1.15-006 - Enriched Environment and Anti-Depressants Enhance Platinum Chemosensitivity of Small Cell Lung Cancer
09:30 - 09:30 | Author(s): Y. Wu
- Abstract
Loading... -
+
P1.15-007 - Randomized Phase III Trial of Enoxaparin in Addition to Standard Treatment in Small Cell Lung Cancer: The RASTEN Trial
09:30 - 09:30 | Presenter: Emelie Gezelius
- Abstract
Loading... -
+
P1.15-008 - Clinical Features and Gene Mutation Profiling of Pulmonary Carcinoid Tumors
09:30 - 09:30 | Presenter: Xiongfei Li
- Abstract
Loading... -
+
P1.15-009 - Safety and Efficacy of Nab-Paclitaxel Monotherapy as 2nd or Later Line Setting in Pts with Extensive SCLC, a Phase II Single Arm Study (NCT02262897)
09:30 - 09:30 | Presenter: Shengxiang Ren
- Abstract
Loading... -
+
P1.15-010 - Small Cell Lung Cancer: Experience of a Portuguese District Hospital
09:30 - 09:30 | Presenter: Margarida Felizardo
- Abstract
Loading... -
+
P1.15-011 - Longitudinal Mutation Monitoring in Plasma Without Matching Tumor Tissue by Deep Sequencing in Small Cell Lung Cancer (SCLC)
09:30 - 09:30 | Presenter: André Rosenthal
- Abstract
Loading... -
+
P1.15-012 - Clinical Prognostic Factors of Elderly Patients with Extensive Stage Small Cell Lung Cancer in Korea
09:30 - 09:30 | Presenter: Jung Sun Kim
- Abstract
Loading... -
+
P1.15-013 - Small Cell Lung Cancer. Methodology and Preliminary Results from the Small Cell Study
09:30 - 09:30 | Presenter: Ángeles Rodríguez
- Abstract
Loading... -
+
P1.15-014 - Can Limited Resection Be Accepted as an Alternative Treatment Option for Patients with Early-Stage Small Cell Lung Cancer?
09:30 - 09:30 | Presenter: Takamasa Koga
- Abstract
Loading... -
+
P1.15-015 - Prognostic Implication of the FEV1/FVC Ratio in Limited-Stage Small Cell Lung Cancer
09:30 - 09:30 | Author(s): O. Cho
- Abstract
Loading... -
+
P1.15-016 - The Study of Population Pharmacokinetics and Individualized Dosage of Lobaplatin-Based Regimens in Elderly Patients with Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Ying Cheng
- Abstract
Loading... -
+
P1.15-017 - Adoption of Prophylactic Cranial Irradiation for Extensive Stage Small Cell Lung Cancer: A Population Based Outcomes Study
09:30 - 09:30 | Author(s): Y.Y. Soon
- Abstract
Loading...
-
+
P1.16 - Surgery
- Type: Poster Session with Presenters Present
- Track: Surgery
- Presentations: 28
- Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P1.16-001 - Characteristics of Resected Lung Cancer in Patients Aged under 60: A Single–Center Experience
09:30 - 09:30 | Presenter: Jeong Su Cho
- Abstract
Loading... -
+
P1.16-002 - Management of Local Recurrence after Segmentectomy for Stage IA Lung Cancer
09:30 - 09:30 | Presenter: Takeshi Mori
- Abstract
Loading... -
+
P1.16-003 - Learning Curve for Adoption of Robotic Lobectomy for Early Stage Non-Small Cell Lung Cancer by a Thoracic Surgeon Experienced in Open Lobectomy
09:30 - 09:30 | Presenter: Shea Gallagher
- Abstract
Loading... -
+
P1.16-004 - Intubated Versus Non-intubated Anesthesia for Lung Cancer VATS in Octogenerians
09:30 - 09:30 | Presenter: Nenad Ilic
- Abstract
Loading... -
+
P1.16-005 - Comparison Sublobar vs Lobar Resection in Early Stage Lung Cancer in Octagenarian Patients
09:30 - 09:30 | Presenter: Sira Laohathai
- Abstract
Loading... -
+
P1.16-006 - Less Is More: video Assisted Thoracic Surgery (VATS) vs Open Thoracotomy in the Management of Resectable Lung Cancer
09:30 - 09:30 | Presenter: Shagufta Shaheen
- Abstract
Loading... -
+
P1.16-007 - Mobile Computed Tomography in Video-Assisted Thoracoscopic Surgery for Ground-Glass Opacity Lung Nodules
09:30 - 09:30 | Presenter: Kouhei Tajima
- Abstract
Loading... -
+
P1.16-008 - Near-Infrared Fluorescence-Guided Pulmonary Segmentectomy Following Endobronchial Indocyanine Green Injection
09:30 - 09:30 | Presenter: Hironobu Wada
- Abstract
Loading... -
+
P1.16-009 - Comparing Lymph Node Dissection in VATS versus Open Lung Cancer Surgery: How, How Long, and How Does It Matter?
09:30 - 09:30 | Author(s): E. Yeung
- Abstract
Loading... -
+
P1.16-010 - Development of a Novel Surgical Marking Method Using Low Power Laser Light
09:30 - 09:30 | Presenter: Keishi Ohtani
- Abstract
Loading... -
+
P1.16-011 - The Role of 3D-CT in Patients with Pulmonary Malignancies Undergoing Segmentectomy
09:30 - 09:30 | Presenter: Ali Amiraliev
- Abstract
Loading... -
+
P1.16-012 - Application of Fluorescent and Iodized Dual Marker for Pre-Operative Localization and Image-Guided Surgery of Pulmonary Nodule
09:30 - 09:30 | Presenter: Jiyun Rho
- Abstract
Loading... -
+
P1.16-013 - Video-Assisted Thoracoscopic Surgery (VATS) versus Thoracotomy in Locally-Advanced Lung Cancers – a Meta-Analysis
09:30 - 09:30 | Presenter: Gerald Sng
- Abstract
Loading... -
+
P1.16-014 - The Efficacy of Thoracoscopic Right Upper Lobectomy Using Fissureless Technique in Patients with Dense Fissures
09:30 - 09:30 | Presenter: Hitoshi Igai
- Abstract
Loading... -
+
P1.16-015 - miMRST Thoracotomy Cures Aged, Sickly Weak and/or Cardiopulmonary Dysfunction Patients with Lung Cancer
09:30 - 09:30 | Presenter: Jun Zhang
- Abstract
Loading... -
+
P1.16-016 - Comparing Safety and Effectiveness of Image-Guided VATS Versus Conventional VATS for Small or Deep Pulmonary Nodules
09:30 - 09:30 | Presenter: Yin Kai Chao
- Abstract
Loading... -
+
P1.16-017 - Middle Term Survival Outcome of Single Port Video Assisted Thoracoscopic Anatomic Lung Resection: Two Center Experience
09:30 - 09:30 | Presenter: Ching Feng Wu
- Abstract
Loading... -
+
P1.16-018 - Intraoperative Detection of Tumor Resection Margin via Inhalation of Fluorescent Imaging Agents
09:30 - 09:30 | Presenter: Yu Hua Quan
- Abstract
Loading... -
+
P1.16-019 - Three Dimensional CT Angio-Bronchography Doesn't Contribute to the Shortening of the Operation Time in Segmentectomy
09:30 - 09:30 | Presenter: Hirohisa Horinouchi
- Abstract
Loading... -
+
P1.16-020 - Outcomes of Pulmonary Metastasectomy in Hepatocellular Carcinoma According to Approach Method-Thoracoscopic Versus Open Approach
09:30 - 09:30 | Presenter: Hyeong Ryul Kim
- Abstract
Loading... -
+
P1.16-021 - Midterm Oncologic Outcomes of Single Port Thoracoscopic Lobectomy for Lung Cancer by Propensity Matched Analysis
09:30 - 09:30 | Presenter: Kook Nam Han
- Abstract
Loading... -
+
P1.16-022 - Incorporating Robotics to the Surgical Treatment of Thoracic Neoplasms: 5-Year Experience at an Academic Center
09:30 - 09:30 | Presenter: Dao Minh Nguyen
- Abstract
Loading... -
+
P1.16-023 - A Useful and Safe Method of Intraoperative Localization of Small-Sized Peripheral Pulmonary Lesions
09:30 - 09:30 | Presenter: Yujiro Kubo
- Abstract
Loading... -
+
P1.16-024 - A Case of Bronchial Atresia Treated with Complete Thoracoscopy-Assisted Right S6 Segmentectomy Using Fluorescence Navigation
09:30 - 09:30 | Presenter: Mototsugu Watanabe
- Abstract
Loading... -
+
P1.16-025 - Safety of Simultaneous TEVAR and Combined Aortic Wall Resection at the Time of Lung Resection for T4 Lung Cancer Infiltrating the Aorta
09:30 - 09:30 | Presenter: Masanori Tsuchida
- Abstract
Loading... -
+
P1.16-026 - Multimodal Image-Guided VATS Resection of Sub-Centimeter Pulmonary Nodules by Cone Beam CT and Bronchoscopic NIR Fluorescence Marking
09:30 - 09:30 | Presenter: Takashi Anayama
- Abstract
Loading... -
+
P1.16-027 - Robotic Surgery, VATS, and Open Surgery for Early Stage Lung Cancer: Comparison of Costs and Outcomes at a Single Institute
09:30 - 09:30 | Presenter: Pierluigi Novellis
- Abstract
Loading... -
+
P1.16-028 - Is Video-Assisted Thoracic Surgery a Safer Procedure for Lung Cancer Patients?
09:30 - 09:30 | Presenter: Maria Teresa Ruiz Tsukazan
- Abstract
Loading...
-
+
P1.17 - Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Type: Poster Session with Presenters Present
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Presentations: 20
- Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P1.17-001 - The Optimal First-Line Treatment for Advanced Thymic Carcinomas
09:30 - 09:30 | Presenter: Xue Yang
- Abstract
Loading... -
+
P1.17-002 - Clinicopathological Significance of Epithelial Mesenchymal Transition in Thymic Cancer
09:30 - 09:30 | Presenter: Yasushi Shintani
- Abstract
Loading... -
+
P1.17-003 - Identification of Differentially Expressed Genes between Thymoma and Paraneoplastic Thymic Tissue
09:30 - 09:30 | Presenter: Lei Yu
- Abstract
Loading... -
+
P1.17-004 - Extrapleural Pneumonectomy for Patients with Stage IVa Thymoma: Pathological Evaluation of Disseminated Pleural Nodules
09:30 - 09:30 | Presenter: Shota Nakamura
- Abstract
Loading... -
+
P1.17-005 - Pure Red Cell Aplasia Associated with Thymoma: A Report of a Single-Center Experience
09:30 - 09:30 | Presenter: Satoru Moriyama
- Abstract
Loading... -
+
P1.17-006 - Radiographic Assessment for Tumor Responses of Thymic Carcinoma Using the ITMIG Modified Criteria
09:30 - 09:30 | Presenter: Taiki Hakozaki
- Abstract
Loading... -
+
P1.17-008 - Clinical and Oncological Outcomes on Resected Thymomas over a Decade at the National Cancer Institute at Mexico City
09:30 - 09:30 | Author(s): R.A. López Saucedo
- Abstract
Loading... -
+
P1.17-009 - Clinical Significance of Preoperative Neutrophil-Lymphocyte Ratio in Patients with Thymic Epithelial Tumor Undergoing Surgery
09:30 - 09:30 | Presenter: Satoru Okada
- Abstract
Loading... -
+
P1.17-010 - The Diagnostic Value of Serum Cytokeratin Fragment 19 (CYFRA21-1) for Thymic Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Haruhiko Shiiya
- Abstract
Loading... -
+
P1.17-011 - Efficacy and Toxicities of Gemcitabine and Cisplatin Combination Chemotherapy in Advanced Thymoma and Thymic Carcinoma
09:30 - 09:30 | Author(s): Y. Wang
- Abstract
Loading... -
+
P1.17-012 - Thymic Neoplasms: The Experience of a Cancer Institute
09:30 - 09:30 | Presenter: Rita Vitorino
- Abstract
Loading... -
+
P1.17-013 - Prognostic Impact of Programmed Cell Death-1 (PD-1) and PD-Ligand 1 (PD-L1) Expression in Thymic Cancer
09:30 - 09:30 | Presenter: Soichiro Funaki
- Abstract
Loading... -
+
P1.17-014 - Platinum Rechallenge in Advanced Thymic Epithelial Tumors: Still an Option in the Age of Target Therapy? A Monocentric Experience
09:30 - 09:30 | Presenter: Margaret Ottaviano
- Abstract
Loading... -
+
P1.17-015 - Long Acting Octreotide plus Prednisone in Advanced Thymic Epithelial Tumors: A Real Life Clinical Experience
09:30 - 09:30 | Presenter: Margaret Ottaviano
- Abstract
Loading... -
+
P1.17-016 - Immunohistochemical Markers as Prognostic Factors in Malignant Thymic Epithelial Tumors
09:30 - 09:30 | Presenter: Yoshito Yamada
- Abstract
Loading... -
+
P1.17-017 - Usefulness of FDG-PET for Differentiating Thymic Epithelial Tumors from Malignant Lymphomas
09:30 - 09:30 | Presenter: Hiroyuki Sakamaki
- Abstract
Loading... -
+
P1.17-018 - Distribution of Ectopic Thymus in Chinese Patients: A Preliminary Study
09:30 - 09:30 | Presenter: Jian-Yong Ding
- Abstract
Loading... -
+
P1.17-019 - B7-H3 Protein Expression in Thymic Epithelial Tumour Subtypes and Its Association with PD-L1 and Clinical Characteristics
09:30 - 09:30 | Presenter: Spyridon Gennatas
- Abstract
Loading... -
+
P1.17-019a - Pathological Discrepancies in the Diagnosis of Thymic Malignancies: The Tallinn-Lyon Experience
09:30 - 09:30 | Presenter: K. Oselin
- Abstract
Loading... -
+
P1.17-019b - Acute and Late Toxicities in the Management of Malignant Thymomas After Subtotal Resection, Chemotherapy and Radiotherapy
09:30 - 09:30 | Presenter: Jan Stejskal
- Abstract
Loading...
-
+
ES 01 - New TNM and WHO Classification
- Type: Educational Session
- Track: Radiology/Staging/Screening
- Presentations: 5
- Moderators:M. Noguchi
- Coordinates: 10/16/2017, 11:00 - 12:30, Room 301 + 302
-
+
ES 01.01 - New TNM Classification
11:00 - 11:20 | Presenter: Ramon Rami-Porta
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES 01.02 - New Histological Classification
11:20 - 11:40 | Presenter: William D Travis
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES 01.03 - Immunohistochemistry, Chromosomal and DNA Analysis, and Molecular Testing
11:40 - 12:00 | Presenter: Yasushi Yatabe
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES 01.04 - Staging and Pathology of Multiple Nodules Presenting in the Lungs
12:00 - 12:20 | Presenter: Andrew G Nicholson
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES 01.05 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
ES 02 - Diagnostic and Interventional Radiology in Lung Cancer: Update 2017
- Type: Educational Session
- Track: Radiology/Staging/Screening
- Presentations: 6
- Moderators:David F Yankelevitz
- Coordinates: 10/16/2017, 11:00 - 12:30, Room 315
-
+
ES 02.01 - The Dutch-Belgian Lung Cancer Screening Trial (NELSON)
11:00 - 11:15 | Presenter: Harry J De Koning
- Abstract
- Presentation
Loading...Information from this presentation has been removed upon request of the author.
-
+
ES 02.02 - The Fleischner Guideline / Lung-RADs
11:15 - 11:30 | Presenter: Matthew Eric Callister
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES 02.03 - Radiologic Implications of the WHO Classification for Lung Cancer
11:30 - 11:45 | Presenter: Kavita Garg
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES 02.04 - Interventional Radiology on Personalized Medicine for Lung Cancer
11:45 - 12:00 | Presenter: Tae Jung Kim
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES 02.05 - MRI and Advanced Applications for Lung Cancer
12:00 - 12:15 | Presenter: Yoshiharu Ohno
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES 02.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
GR 01 - What to Do at the Time of Progression on Targeted Therapy
- Type: Grand Rounds
- Track: Chemotherapy/Targeted Therapy
- Presentations: 6
- Moderators:D. Kim
- Coordinates: 10/16/2017, 11:00 - 12:30, Room 303 + 304
-
+
GR 01.01 - Case Study
11:00 - 11:05 | Presenter: D. Kim
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
GR 01.02 - Case Study
11:05 - 11:10 | Presenter: Lecia V Sequist
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
GR 01.03 - First-Line Management of EGFR Mutant NSCLC
11:10 - 11:30 | Presenter: Li Zhang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
GR 01.04 - EGFR-Positive NSCLC Cases Who Failed Previous EGFR-TKI
11:30 - 11:50 | Presenter: Gregory J Riely
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
GR 01.05 - First-Line Management of ALK Mutant NSCLC
11:50 - 12:10 | Presenter: Silvia Novello
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
GR 01.06 - ALK-Positive NSCLC Cases who Failed Previous ALK Inhibitors
12:10 - 12:30 | Presenter: Jürgen Wolf
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA 01 - SCLC: Research Perspectives
- Type: Mini Oral
- Track: SCLC/Neuroendocrine Tumors
- Presentations: 12
- Moderators:John V Heymach
- Coordinates: 10/16/2017, 11:00 - 12:30, Room 503
-
+
MA 01.01 - Metastatic Behavior of Pulmonary Neuroendocrine Carcinomas Is Associated with Epithelial to Mesenchymal Transition Gene Profile
11:00 - 11:05 | Presenter: Tabatha Gutierrez Prieto
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 01.02 - Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers Versus Heavy Smokers
11:05 - 11:10 | Presenter: Andrés F. Cardona
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 01.03 - The Potential of ctDNA Sequencing in Disease Monitoring and Depicting Genomic Evolution of Small-Cell Lung Cancer Under Therapy
11:10 - 11:15 | Author(s): J. Wang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 01.04 - Discussant - MA 01.01, MA 01.02, MA 01.03
11:15 - 11:30 | Presenter: Charles Andrew Butts
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 01.05 - Activity and Safety of the Combination of PM01183 and Doxorubicin in Relapsed SCLC. Final Results of a Phase Ib Trial
11:30 - 11:35 | Presenter: Emiliano Calvo
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 01.06 - A Phase II Study of Etirinotecan Pegol (NKTR-102) in Patients with Chemotherapy-Resistant Small Cell Lung Cancer
11:35 - 11:40 | Presenter: Hongbin Chen
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 01.07 - Lanreotide Maintenance in SCLC Expressing Somatostatine Receptors: Efficacy Results of Multicenter Randomized G04.2011 Trial
11:40 - 11:45 | Presenter: Sara Pilotto
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 01.08 - Discussant - MA 01.05, MA 01.06, MA 01.07
11:45 - 12:00 | Presenter: Anne Tsao
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 01.09 - Treatment Patterns in Extensive Disease Small Cell Lung Cancer Across the United States, Europe, and Japan
12:00 - 12:05 | Author(s): K. Higginbottom
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 01.10 - Outcome Based on Baseline Total Lymphocyte Count & Neutrophil-To-Lymphocyte Ratio in Extensive Stage Small-Cell Lung Cancer
12:05 - 12:10 | Presenter: Ryoko Suzuki
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 01.11 - Timing of Thoracic Radiotherapy Is More Important Than Dose Escalation in Patients with Limited-Stage Small Cell Lung Cancer
12:10 - 12:15 | Presenter: Xiao Hu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 01.12 - Discussant - MA 01.09, MA 01.10, MA 01.11
12:15 - 12:30 | Presenter: Anand Swaminath
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA 02 - Emerging Targets
- Type: Mini Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Presentations: 12
- Moderators:Ravi Salgia
- Coordinates: 10/16/2017, 11:00 - 12:30, Room 511 + 512
-
+
MA 02.01 - Evidence of Clinical Activity of Sitravatinib in Combination with Nivolumab in NSCLC Patients Progressing on Prior Checkpoint Inhibitors
11:00 - 11:05 | Presenter: Ticiana A. Leal
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 02.02 - Phase 2 Study of Pembrolizumab Plus CC-486 vs Pembrolizumab Plus Placebo in Previously Treated Patients with Advanced NSCLC
11:05 - 11:10 | Author(s): B.P. Levy
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 02.03 - Selective Histone Deacetylase Inhibitor ACY-241 Plus Nivolumab for Refractory Advanced NSCLC: Results From a Phase 1b Study
11:10 - 11:15 | Presenter: Mark Awad
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 02.04 - Discussant - MA 02.01, MA 02.02, MA 02.03
11:15 - 11:30 | Presenter: Grace K Dy
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 02.05 - Nivolumab in Advanced Non-Squamous NSCLC Patients with KRAS Mutations: Results from the Italian Expanded Access Program (EAP)
11:30 - 11:35 | Author(s): A. Ardizzoni
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 02.06 - BRAF Mutant NSCLC: Correlation with PD-L1 Expression,TMB, MSI and Response to ICPi and Anti-BRAF Therapy
11:35 - 11:40 | Presenter: Elizabeth Dudnik
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 02.07 - A Phase II Study of Pembrolizumab in EGFR Mutant, PD-L1+, Tyrosine Kinase Inhibitor (TKI) Naïve Patients with Advanced NSCLC
11:40 - 11:45 | Presenter: Aaron Lisberg
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 02.08 - Discussant - MA 02.05, MA 02.06, MA 02.07
11:45 - 12:00 | Presenter: Barbara Melosky
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 02.09 - A Ph I/II Study of BGB324, a Selective AXL Inhibitor as Monotherapy and in Combination with Erlotinib in Advanced NSCLC
12:00 - 12:05 | Presenter: Don Lynn Gibbons
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 02.10 - Phase I Study of ABBV-399 (Telisotuzumab Vedotin) as Monotherapy and in Combination with Erlotinib in NSCLC
12:05 - 12:10 | Presenter: Jonathan Wade Goldman
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 02.11 - A Phase I Trial of Erlotinib and Onalespib in EGFR-mutant NSCLC: Focus on EGFR Exon 20 Insertions
12:10 - 12:15 | Presenter: Jonathan W Riess
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA 02.12 - Discussant - MA 02.09, MA 02.10, MA 02.11
12:15 - 12:30 | Presenter: Dean A Fennell
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.